참고문헌
- Arvelo F, Cotte, C. Metalloproteinases in tumor progression. Review Invest Clin 2006;47(2) :185-205.
- Baek WK, Park JW, Lim JH, Suh SI, Suh MH, Gabrielson E, et al. Molecular cloning and characterization of the human budding uninhibited by benomyl (BUB3) promoter. Gene 2002;295(1):117-23. https://doi.org/10.1016/S0378-1119(02)00827-2
- Gao Z, Sasaoka T, Fujimori T, Oya T, Ishii Y, Sabit H, et al. Deletion of the PDGFR-beta gene affects key fibroblast functions important for wound healing. J Biol Chem 2005;280(10) :9375-89. https://doi.org/10.1074/jbc.M413081200
- Hrabec E, Strek M, Nowak D, Greger J, Suwalski M, Hrabec Z. Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas: a quantitative analysis. J Cancer Res Clin Oncol 2002;128(4):197-204. https://doi.org/10.1007/s00432-001-0320-3
-
Jiang J, Grieb B, Thyagarajan A, Sliva D. Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-
${\kappa}B$ signaling. Int J Mol Med 2008;21(5):577-84. - Johnsen M, Lund LR, Romer J, Almholt K, Dano K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 1998;10(5):667-71. https://doi.org/10.1016/S0955-0674(98)80044-6
- Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 1995;55(9):1856-62.
- Komae H, Hayashi H. Phytosterols of the trunks of Lindera obtusiloba. Phytochemistry 1972;11:1182. https://doi.org/10.1016/S0031-9422(00)88485-X
- Kim MM, Ta QV, Mendis E, Rajapakse N, Jung WK, Byun HG, et al. Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity. Life Sci 2006;79(15):1436-43. https://doi.org/10.1016/j.lfs.2006.04.022
- Kim SH, Son JH, Lee SH. Inhibitory effects of water extract of Lindera obtusiloba on the mast cell-mediated allergic inflammation. Kor J Pharmacogn 2009;40(3):233-7.
- Kwon HC, Baek NI, Choi SU, Lee KR. New cytotoxic butanolides from Lindera obtusiloba BLUME. Chem Pharm Bull 2000;48(5):614-6. https://doi.org/10.1248/cpb.48.614
- Kwon HC, Choi SU, Lee JO, Bae KH, Zee OP, Lee KR. Two new lignans from Lindera obtusiloba blume. Arch Pharm Res 1999;22(4) :417-22. https://doi.org/10.1007/BF02979069
- Lee KY, Kim SH, Jeong EJ, Park JH, Kim SH, Kim YC, et al. New secoisolariciresinol derivatives from Lindera obtusiloba stems and their neuroprotective activities. Planta Med 2010;76(3):294-7. https://doi.org/10.1055/s-0029-1186053
- Liabakk NB, Talbot I, Smith RA, Wilkinson K, Balkwill F. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 1996;56(15):190-6.
-
Lind DS, Hochwald SN, Malaty J, Rekkas S, Heby P, Mishra G. Nuclear factor-
${\kappa}B$ is unregulated in colorectal cancer. Surgery 2001; 130(2):363-9. https://doi.org/10.1067/msy.2001.116672 - McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 2000;6(4):149-56. https://doi.org/10.1016/S1357-4310(00)01686-5
-
Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Sledge GW. Constitutive activation of NF-
${\kappa}B$ during progression of breast cancer to hormone independent growth. Mol Cell Biol 1997;17(7):3629-39. https://doi.org/10.1128/MCB.17.7.3629 - Niwa M, Iguchi M, Yamamura S. Three new obtusilactones from Lindera obtusiloba Blume. Chemistry Letters 1975;4:655-8. https://doi.org/10.1246/cl.1975.655
- Oppenheimer SB. Cellular basis of cancer metastasis: A review of fundamentals and neadvances. Acta Histochem 2006;108(5):327-34. https://doi.org/10.1016/j.acthis.2006.03.008
- Zhao W, Liu H, Xu S, Entschladen F, Niggemann B, Zänker KS, et al. Migration and metalloproteinases determine the invasive potential of mouse melanoma cells, but not melanin and telomerase. Cancer Lett 2001;162:S49-S55. https://doi.org/10.1016/S0304-3835(00)00656-X
- Ruehl M, Erben U, Kim K, Freise C, Dagdelen T, Eisele S, et al. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta -mediated profibrotic gene expression pattern. J Nutr Biochem 2009;20(8):597-606. https://doi.org/10.1016/j.jnutbio.2008.06.003
- Scorilas A, Karameris A, Arnogiannaki N, Ardavanis A, Bassilopoulos P, Trangas T, et al. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Br J Cancer 2001;84(11):1488-96. https://doi.org/10.1054/bjoc.2001.1810
- Shishodia S, Majumdar S, Banerjee S, Aggarwal BB. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res 2003;63(15):4375-83.
- Tryggvason K, Hoyhtya M, Salo T. Proteolytic degradation of extracellularmatrix in tumor invasion. Biochimica et Biophysica Acta 1987; 907(3):191-217.
- Yang J, Richmond A. Constitutive IkappaB kinase activity correlates with nuclear factorkappaB activation in human melanoma cells. Cancer Res 2001;61(12):4901-9.
- Yeh CT, Wu CH, Yen GC. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling. Mol Nutr Food Res 2010;54(9):1285-95. https://doi.org/10.1002/mnfr.200900414
- Yook C. Lindera obtusiloba. Medical plants of Korea. Seoul: Jinmyeong Publishing Co.; 1989, p. 184.
- Yoon SO, Park SJ, Yun CH, Chung AS. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol 2003; 36(1):128-37. https://doi.org/10.5483/BMBRep.2003.36.1.128